The Göttingen Campus

The Göttingen location has come to be synonymous with high-quality international research. To ensure that this remains the case in the future, the University of Göttingen, including the University Medical Center, and eight non-university local research centres have joined forces to form the Göttingen Campus.

By drawing on their joint strengths and potential, campus partners have created a unique and stimulating environment that encourages diversity and an active exchange between professors, researchers and doctoral students.

Across the Göttingen Campus, there are currently more than 5,900 researchers working in nearly every scientific discipline.

Within the Göttingen Campus, the quality of teaching and training of early career scientists is assured and continuously improved by joint graduate programmes and inter-institute junior research groups.

Science on campus benefits from excellent joint third-party funded projects and 23 joint professorships between the University and non-university institutions.

Latest news

  • The Sunrise III mission will look at the Sun from the stratosphere equipped with three new scientific instruments.
    In the summer of 2022, the balloon-borne solar observatory Sunrise will embark on its third stratospheric flight. From the airborne observation site more than 35 kilometers above the Earth's surface, the observatory will enjoy a unique view of the Sun during the several-day flight from northern Sweden to Canada: around the clock, undisturbed by air turbulences in the Earth's atmosphere, and with access to the ultraviolet radiation from our star.…
    Read more
  • Das Impfzentrum für die Mitarbeitenden der Universitätsmedizin Göttingen (UMG) zieht nach der ersten Woche Arbeit eine positive Zwischenbilanz: Knapp 600 UMG Beschäftigte wurden geimpft, die neuen Räumlichkeiten am 14. Januar 2021 bezogen. Künftig können dort täglich 200 bis 300 Mitarbeitende geimpft werden. UMG wartet auf die nächste Lieferung des Impfstoffs.
    Am Donnerstag, dem 14. Januar 2021, öffnete das UMG-eigene Impfzentrum seine Türen. Die Universitätsmedizin Göttingen (UMG) hat in den neuen Räumen die Impfungen für ihre Mitarbeiter*innen fortgesetzt. Bereits am ersten Tag impften die Betriebsärzt*innen der UMG in einem ersten Schritt über 120 Mitarbeit*innen in der Reihenfolge fest vergebener Termine. Zusammen mit den bereits in der zurückliegenden Woche Geimpften werden bis zum Freitag über…
    Read more
  • Research team led by Göttingen University investigates molecular basis of eye size variation in insects
    The fascinating compound eyes of insects consist of hundreds of individual eyes known as “facets”. In the course of evolution, an enormous variety of eye sizes and shapes has emerged, often representing adaptations to different environmental conditions. Scientists, led by an Emmy Noether research group at the University of Göttingen, together with scientists from the Andalusian Centre for Developmental Biology (CABD) in Seville, have now shown…
    Read more
  • Physicist from Göttingen University receives European Research Council Advanced Grant
    Physicist Professor Jörg Enderlein from the University of Göttingen has been awarded an Advanced Grant by the European Research Council (ERC). The ERC has supported Enderlein's project – "Single-molecule, metal-induced energy transfer" – since the beginning of January 2021. The grant is worth a total of around 2.8 million euros and will run for five years. The ERC Advanced Grants scheme funds ground-breaking projects led by outstanding and…
    Read more
  • Remdesivir is the first drug against Covid-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral copying machine, called RNA polymerase. Researchers at the Max Planck Institute (MPI) for Biophysical Chemistry in Göttingen and the University of Würzburg have now elucidated how remdesivir interferes with the viral polymerase during copying and why it does not inhibit it completely. Their results explain why the drug has a rather weak effect. (Nature Communications, January 12, 2021)
    “After complicated studies, we come to a simple conclusion,” Max Planck Director Patrick Cramer says. “Remdesivir does interfere with the polymerase while doing its work, but only after some delay. And the drug does not fully stop the enzyme.”  At the pandemic’s beginning, Cramer’s team at the MPI for Biophysical Chemistry had elucidated how the coronavirus duplicates its RNA genome. For the pathogen this is a colossal task as its genome…
    Read more